U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364331) titled 'Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)' on April 25, 2024.
Brief Summary: This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Study Start Date: Sept. 04, 2021
Study Type: INTERVENTIONAL
Condition:
ADHD
Children
Adolescents
Intervention:
DIETARY_SUPPLEMENT: Omega-3
EPA or DHA
DIETARY_SUPPLEMENT: Placebo
olive oil
Recruitment Status: RECRUITING
Sponsor: China Medical University Hospital
Information provided by (Responsible Party): Pei-Chen Chang, China M...